Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Solomon Iyasu"'
Autor:
Nancy A Dreyer, Miriam C. J. M. Sturkenboom, Sengwee Toh, Noelle M. Cocoros, Solomon Iyasu, Chieko Ishiguro, Wei Zhou, Peter Arlett
Publikováno v:
Clinical Pharmacology & Therapeutics. 109:1189-1196
A fundamental question in using real-world data for clinical and regulatory decision making is: How certain must we be that the algorithm used to capture an exposure, outcome, cohort-defining characteristic, or confounder is what we intend it to be?
Publikováno v:
Pharmacoepidemiology and drug safetyREFERENCES. 30(6)
There is increasing interest in utilizing real-world data (RWD) to produce real-world evidence (RWE) on the benefits and risks of medical products that could support regulatory approval decisions. The field of pharmacoepidemiology has a long history
Autor:
Esther H. Zhou, Sally Seymour, Solomon Iyasu, Elizabeth M. Kang, Margie R. Goulding, Jacqueline M. Major
Publikováno v:
Journal of Asthma and Allergy
Esther H Zhou,1 Sally Seymour,2 Margie R Goulding,1 Elizabeth M Kang,1 Jacqueline M Major,1 Solomon Iyasu1 1Division of Epidemiology, Office of Surveillance and Epidemiology, 2Office of New Drugs, Center for Drug Evaluation and Research, US Food and
Autor:
Esther H. Zhou, Tracy M. Pham, Mary E. Willy, Hina Mehta, Solomon Iyasu, Judy A. Staffa, Hui-Lee Wong, Yulan Ding, Jacqueline M. Major, Cunlin Wang, James Phillip Trinidad
Publikováno v:
Pharmacoepidemiology and Drug Safety. 25:590-598
PURPOSE: The goal of this study is to summarize trends in rates of adverse events attributable to acetaminophen use, including hepatotoxicity and mortality. METHODS: A comprehensive analysis of data from three national surveillance systems estimated
Autor:
Yute Wu, Aarthi Iyer, Ann Chen Wu, Pingsheng Wu, Esther H. Zhou, Meghan A Baker, Solomon Iyasu, Sally Seymour, Melissa G. Butler, Sengwee Toh, Mark Levenson, Fang Zhang
Publikováno v:
The Journal of asthma : official journal of the Association for the Care of Asthma. 55(8)
OBJECTIVE: Evidence of safety issues associated with long-acting beta(2)-agonist (LABA) treatment has led to multiple regulatory activities by the U.S. Food and Drug Administration (FDA) on this class of medications. This study describes the impact o
Publikováno v:
Journal of Asthma. 51:1061-1067
To evaluate changes in the dispensing patterns of long-acting beta2-adrenergic agonist (LABA) in pediatric and adolescent asthma patients in relation to multiple Food and Drug Administration (FDA) regulatory activities from 2003 to 2011.We estimated
Autor:
Yute Wu, Yulan Ding, Tarek A. Hammad, Sigal Kaplan, Andrew D. Mosholder, Esther H. Zhou, Solomon Iyasu, David Moeny
Publikováno v:
Journal of Asthma. 50:990-995
This study investigates the potential association between montelukast use and psychiatric adverse events by monitoring changes in antidepressant medication dispensing rates before and after initiating montelukast.The primary study group of montelukas
Publikováno v:
Journal of Asthma. 49:1079-1085
Objective. Because of the serious safety risks, Food and Drug Administration (FDA) has recommended that long-acting beta2-adrenergic agonists (LABAs) be reserved for patients whose asthma cannot be adequately managed with asthma control medication. T
Autor:
Melissa G. Butler, Yute Wu, Solomon Iyasu, Sengwee Toh, Pingsheng Wu, Esther H. Zhou, Aarthi Iyer, Sally Seymour, Mark Levenson, Fang Zhang, Ann Chen Wu, Meghan A Baker
Background Safety concerns associated with long-acting β 2 -agonists (LABAs) have led to many US Food and Drug Administration (FDA) regulatory activities for this class of drugs. Little is known about the effect of these regulatory activities on use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a76b55785a61c44d1be20d73f6bef974
https://europepmc.org/articles/PMC7065027/
https://europepmc.org/articles/PMC7065027/
Publikováno v:
American Journal of Public Health. 96:2222-2227
Objectives. To describe changes in infant mortality rates, including birthweight-specific rates and rates by age at death and cause. Methods. We analyzed US linked birth/infant-death data for 1989–1991 and 1998–2000 for American Indians/Alaska Na